|
Originally published In Press as doi:10.1074/jbc.M106215200 on September 11, 2001
J. Biol. Chem., Vol. 276, Issue 46, 42692-42699, November 16, 2001
Identification of Determinants of Inverse Agonism in a
Constitutively Active Parathyroid Hormone/Parathyroid Hormone-related
Peptide Receptor by Photoaffinity Cross-linking and Mutational
Analysis*
Robert C.
Gensure §,
Percy H.
Carter ,
Brian D.
Petroni ,
Harald
Jüppner , and
Thomas J.
Gardella ¶
From the Endocrine Unit and § Pediatric
Endocrine Unit, Massachusetts General Hospital and Harvard Medical
School, Boston, Massachusetts 02114
We have investigated receptor structural
components responsible for ligand-dependent inverse agonism
in a constitutively active mutant of the human parathyroid hormone
(PTH)/parathyroid hormone-related peptide (PTHrP) receptor type 1 (hP1R). This mutant receptor, hP1R-H223R
(hP1RCAM-HR), was originally identified in Jansen's chondrodysplasia and is altered in transmembrane domain (TM) 2. We
utilized the PTHrP analog,
[Bpa2,Ile5,Trp23,Tyr36]PTHrP-(1-36)-amide
(Bpa2-PTHrP-(1-36)), which has valine 2 replaced by
p-benzoyl-L-phenylalanine (Bpa); this
substitution renders the peptide a photoreactive inverse agonist at
hP1RCAM-HR. This analog cross-linked to
hP1RCAM-HR at two contiguous receptor regions as follows:
the principal cross-link site (site A) was between receptor residues
Pro415-Met441, spanning the TM6/extracellular
loop three boundary; the second cross-link site (site B) was within the
TM4/TM5 region. Within the site A interval, substitution of
Met425 to Leu converted Bpa2-PTHrP-(1-36) from
an inverse agonist to a weak partial agonist; this conversion was
accompanied by a relative shift of cross-linking from site A to site B. The functional effect of the M425L mutation was specific for
Bpa2-containing analogs, as inverse agonism of
Bpa2-PTH-(1-34) was similarly eliminated, whereas inverse
agonism of
[Leu11,D-Trp12]PTHrP-(5-36) was
not affected. Overall, our data indicate that interactions between
residue 2 of the ligand and the extracellular end of TM6 of the hP1R
play an important role in modulating the conversion between active and
inactive receptor states.
*
This work was supported by National Institutes of Health
Grant DK11794 and National Research Service Award 1F32DK10034-01.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed. Tel.:
617-726-3966, Fax: 617-726-7543; E-mail:
gardella@helix.mgh.harvard.edu.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. J. Gardella
Mimetic Ligands for the PTHR1: Approaches, Developments, and Considerations
IBMS BoneKEy,
February 1, 2009;
6(2):
71 - 85.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. H. Carter, R.-Q. Liu, W. R. Foster, J. A. Tamasi, A. J. Tebben, M. Favata, A. Staal, M. E. Cvijic, M. H. French, V. Dell, et al.
Discovery of a small molecule antagonist of the parathyroid hormone receptor by using an N-terminal parathyroid hormone peptide probe
PNAS,
April 17, 2007;
104(16):
6846 - 6851.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Dean, A. Linglart, M. J. Mahon, M. Bastepe, H. Juppner, J. T. Potts Jr., and T. J. Gardella
Mechanisms of Ligand Binding to the Parathyroid Hormone (PTH)/PTH-Related Protein Receptor: Selectivity of a Modified PTH(1-15) Radioligand for G{alpha}S-Coupled Receptor Conformations
Mol. Endocrinol.,
April 1, 2006;
20(4):
931 - 943.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Gensure, B. Ponugoti, Y. Gunes, M. R. Papasani, B. Lanske, M. Bastepe, D. A. Rubin, and H. Juppner
Identification and Characterization of Two Parathyroid Hormone-Like Molecules in Zebrafish
Endocrinology,
April 1, 2004;
145(4):
1634 - 1639.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Pham, J. D. Wade, B. W. Purdue, and P. M. Sexton
Spatial Proximity between a Photolabile Residue in Position 19 of Salmon Calcitonin and the Amino Terminus of the Human Calcitonin Receptor
J. Biol. Chem.,
February 20, 2004;
279(8):
6720 - 6729.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Dong, D. I. Pinon, R. F. Cox, and L. J. Miller
Importance of the Amino Terminus in Secretin Family G Protein-coupled Receptors: INTRINSIC PHOTOAFFINITY LABELING ESTABLISHES INITIAL DOCKING CONSTRAINTS FOR THE CALCITONIN RECEPTOR
J. Biol. Chem.,
January 9, 2004;
279(2):
1167 - 1175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Gensure, N. Shimizu, J. Tsang, and T. J. Gardella
Identification of a Contact Site for Residue 19 of Parathyroid Hormone (PTH) and PTH-Related Protein Analogs in Transmembrane Domain Two of the Type 1 PTH Receptor
Mol. Endocrinol.,
December 1, 2003;
17(12):
2647 - 2658.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. G. Goodman, I. B. Salusky, and H. Juppner
New lessons from old assays: parathyroid hormone (PTH), its receptors, and the potential biological relevance of PTH fragments
Nephrol. Dial. Transplant.,
October 1, 2002;
17(10):
1731 - 1736.
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|